NL-OMON21505已完成3 期
The INVEST study Treatment in advanced Parkinson’s disease: continuous intrajejunal levodopa INfusion VErsus deep brain STimulation.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- ZonMw
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Idiopathic Parkinson's Disease with bradykinesia and at least two of the following signs; resting tremor, rigidity, and asymmetry;
- •- Despite optimal pharmacological treatment, at least one of the following symptoms: severe response fluctuations, dyskinesias, painful dystonia or bradykinesia;
排除标准
- •- Age below 18 years
- •- Previous PD-neurosurgery (e.g., DBS, pallidotomy, thalamotomy);
研究者
相似试验
招募中
不适用
Clinical observation on the treatment of Parkinson's disease with fatigue by three injectionsParkinson's disease fatigueITMCTR2200006777The First Affiliated Hospital of Guangzhou University of Chinese Medicine
尚未招募
1 期
A Clinical Study for the Treatment of Parkinson's Disease with Integrated Shi Shi Tonifying Kidney Pill and Xingnao Kaiqiao AcupunctureParkinson's diseaseITMCTR1900002280ShenZhen JinFangZhenLue Technology Ltd. Co.
已完成
不适用
Treatment in advanced Parkinson*s disease: continuous intrajejunal levodopa infusion versus deep brain stimulation; a feasibility studyParkinson10028037Parkinson's DiseaseNL-OMON39084Academisch Medisch Centrum59
尚未招募
不适用
A Clinical study of Parkinsonâ??s disease and comparativr evaluation of two unani formulations (Combination of jadwar and ood e saleeb with majoon e jograj gogul) in its management.CTRI/2021/09/036722Department of Moalejat
已完成
不适用
Early treatment of idiopathic Parkinson's disease with dopaminergic agonist piribedil in monotherapy. A two-year randomised, parallel, placebo-controlled study in idiopathic Parkinsonian de novo patientsParkinson's diseaseISRCTN36646813Institut de Recherches Internationales Servier (France)400